+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

D4 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

D4 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Glabellar Lines - Pipeline Insight, 2025 - Product Thumbnail Image

Glabellar Lines - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Anorexia - Pipeline Insight, 2025 - Product Thumbnail Image

Anorexia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Tuberculosis - Pipeline Insight, 2025 - Product Thumbnail Image

Tuberculosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Malaria - Pipeline Insight, 2025 - Product Thumbnail Image

Malaria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsing-Remitting Multiple Sclerosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Nosocomial Pneumonia - Pipeline Insight, 2025 - Product Thumbnail Image

Nosocomial Pneumonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Hypertrophic Cardiomyopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Hypertrophic Cardiomyopathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Scars - Pipeline Insight, 2025 - Product Thumbnail Image

Scars - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A1 Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A1 Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2A Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-1 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2A Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A3 Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A3 Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Argininosuccinic Aciduria - Pipeline Insight, 2025 - Product Thumbnail Image

Argininosuccinic Aciduria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Diabetic Cardiomyopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Cardiomyopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more